Back to the main directory
EarningsReview / Equity
- TROP2-QCS biomarker encouraging ahead of AVANZAR readout in 2025 by BNP Paribas Exane
- Sustainability Weekly 2 – 6 September 2024 by Oddo BHF
- Almost showtime for Sensify by BNP Paribas Exane
- by BNP Paribas Exane
- Supply Chain Implications If The DOJ Were To Subpoena Nvidia by BNP Paribas Exane
- VALE, BHP, ACX, APAM, OUT1V, STRATEGY, CHINA CPI, STEEL EU/CHINA by BNP Paribas Exane
- Games Workshop Group - FY24 profit estimates beaten by Edison Investment Research
- Games Workshop Group - Another record year in FY24 by Edison Investment Research
- Shoprite (SHP SJ) by HSBC
- Your questions, our answers by BNP Paribas Exane
- Picton Property Income - Office repurposing progress by Edison Investment Research
- 石药集团（1093 HK） by HSBC
- August global trends: Demand moderating, drivers mixed by BNP Paribas Exane
- The Pebble Group - Improved operational readiness by Edison Investment Research
- Gresham House Energy Storage Fund - Revenue recovery to provide base for growth by Edison Investment Research
- Basilea Pharmaceutica - H2 rewards continue: US$25m Cresemba milestone by Edison Investment Research
- Non material data changes by BNP Paribas Exane
- KID - Initiation of coverage - Top kid on the block by DnB Markets
- Aker BP (Buy, TP: NOK280.00) - Attractive entry point by DnB Markets
- Multiple reasons to BUY by DnB Markets
- ADES building international footprint by DnB Markets
- Takeaways from iPhone 16 launch by BNP Paribas Exane
- Horses for courses by BNP Paribas Exane
- Time to pause by BNP Paribas Exane
- Leveraging the landmark by BNP Paribas Exane